title: Monitoring and managing graft health in the kidney transplant recipient.
abstract: Ongoing monitoring of kidney transplants is a widely accepted and practiced part of posttransplantation management. One reason to monitor is to evaluate whether the transplant is stable. The transplant community evaluates stability by checking kidney function. Despite problems with sensitivity and specificity, obtaining serial serum creatinine levels is the most common approach to assessing kidney function. Some programs supplement serial serum creatinine levels with surveillance kidney biopsies. Although not uniformly accepted as beneficial, surveillance biopsies are useful in select subsets of patients such as highly sensitized recipients. Recent biopsy studies shed light on which histopathology findings portend poor prognoses. The Long-Term Deterioration of Kidney Allograft Function Study (DeKAF) and similar studies that will prospectively evaluate therapeutic interventions should help the transplant community better define how to monitor and manage the kidney transplant optimally. In the meantime, Kidney Diseases: Improving Global Outcomes (KDIGO) provides an evidence-based approach toward monitoring and managing the kidney transplant.
authors: Section of Nephrology, University of Chicago, MC5100, Chicago, IL 60637, USA. mjosephs@medicine.bsd.uchicago.edu
authors: Michelle A
authors: MA
authors: Josephson
mesh_terms: D019317:Evidence-Based Medicine; D006084:Graft Rejection / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006085:Graft Survival; D006801:Humans; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000009:adverse effects; D008134:Long-Term Care; D011183:Postoperative Complications / Q000175:diagnosis* / Q000628:therapy; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D017741:Survivors; D013997:Time Factors